SOLOMON KORSSA: Open Payments
NPI 1306298138 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 9 payments from 7 companies in 2025. Trend: 2023 $415 · 2024 $64 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Gilead Sciences, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAPLYTA, Kerendia, Qelbree, VRAYLAR, Cologuard Collection Kit, ZEPBOUND.
Industry payments across OH — which companies pay providers there.
